Top 5 Stocks to Buy Now
→ SpaceX IPO hides a much bigger story (From Weiss Ratings) (Ad)tc pixel Free PACS Stock Alerts

PACS Group (PACS) Financials

PACS Group logo
$36.67 +0.09 (+0.23%)
Closing price 06/18/2026 03:59 PM Eastern
Extended Trading
$36.38 -0.29 (-0.80%)
As of 06/18/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for PACS Group

Annual Income Statements for PACS Group

This table shows PACS Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 150 113 56 192
Consolidated Net Income / (Loss)		 150 113 55 191
Net Income / (Loss) Continuing Operations		 150 113 55 191
Total Pre-Tax Income 		207 157 102 284
Total Operating Income		 229 208 123 310
Total Gross Profit		 561 664 793 1,159
Total Revenue		 2,422 3,111 4,090 5,289
Operating Revenue		 2,422 3,111 4,090 5,289
Total Cost of Revenue		 1,861 2,448 3,297 4,130
Operating Cost of Revenue		 1,861 2,448 3,297 4,130
Total Operating Expenses		 331 456 670 850
Selling, General & Admin Expense		 149 214 344 415
Depreciation Expense		 22 26 41 56
Other Operating Expenses / (Income)		 160 217 285 379
Total Other Income / (Expense), net		 -22 -50 -22 -25
Interest Expense		 26 50 44 28
Other Income / (Expense), net		 3.22 -0.54 23 3.22
Income Tax Expense		 57 44 46 93
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.01 -0.42 -0.08
Basic Earnings per Share		 $1.17 $0.88 $0.38 $1.23
Weighted Average Basic Shares Outstanding		 128.72M 128.72M 146.66M 156.18M
Diluted Earnings per Share		 $1.17 $0.88 $0.38 $1.22
Weighted Average Diluted Shares Outstanding		 128.72M 128.72M 148.57M 156.70M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 157.17M

Quarterly Income Statements for PACS Group

This table shows PACS Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 20 34 35 -32 16 37 28 51 52 60 81
Consolidated Net Income / (Loss)		 20 34 35 -32 16 36 28 51 52 60 81
Net Income / (Loss) Continuing Operations		 20 34 35 -32 16 36 28 51 52 60 81
Total Pre-Tax Income 		27 49 58 -51 34 61 43 79 76 87 114
Total Operating Income		 36 63 65 -37 23 72 48 80 86 95 120
Total Gross Profit		 151 174 184 174 177 259 253 288 298 319 346
Total Revenue		 789 853 920 936 1,026 1,208 1,277 1,309 1,345 1,358 1,420
Operating Revenue		 789 853 920 936 1,026 1,208 1,277 1,309 1,345 1,358 1,420
Total Cost of Revenue		 638 680 736 762 850 949 1,024 1,021 1,046 1,039 1,075
Operating Cost of Revenue		 638 680 736 762 850 949 1,024 1,021 1,046 1,039 1,075
Total Operating Expenses		 114 111 119 211 154 187 205 208 212 225 226
Selling, General & Admin Expense		 50 42 47 137 71 90 99 100 103 113 112
Depreciation Expense		 6.36 7.28 8.12 9.25 11 13 13 13 14 15 18
Other Operating Expenses / (Income)		 58 62 64 65 73 84 94 94 95 96 96
Total Other Income / (Expense), net		 -9.01 -13 -7.61 -14 11 -11 -5.41 -1.89 -9.97 -7.88 -6.30
Interest Expense		 10 14 16 9.92 9.03 9.30 6.90 4.35 8.53 8.58 6.42
Other Income / (Expense), net		 1.21 0.46 8.49 -3.91 20 -1.48 1.49 2.47 -1.44 0.70 0.13
Income Tax Expense		 7.47 15 23 -19 17 25 14 28 24 27 33
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 0.00 0.00 0.59 -1.01 -0.09 0.00 -0.08 0.08 -0.03
Basic Earnings per Share		 $0.15 $0.28 $0.27 ($0.21) $0.10 $0.22 $0.18 $0.33 $0.33 $0.39 $0.51
Weighted Average Basic Shares Outstanding		 128.72M 128.72M 128.72M 149.46M 153.12M 146.66M 155.18M 156.34M 156.58M 156.18M 157.07M
Diluted Earnings per Share		 $0.15 $0.28 $0.27 ($0.21) $0.10 $0.22 $0.17 $0.31 $0.32 $0.42 $0.50
Weighted Average Diluted Shares Outstanding		 128.72M 128.72M 128.72M 149.46M 158.45M 148.57M 166.42M 165.47M 164.71M 156.70M 162.08M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 24.64M 152.40M - 0.00 - - 156.62M 157.17M 158.27M

Annual Cash Flow Statements for PACS Group

This table details how cash moves in and out of PACS Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 30 20 42 71
Net Cash From Operating Activities		 93 64 367 404
Net Cash From Continuing Operating Activities		 93 64 367 404
Net Income / (Loss) Continuing Operations		 150 113 55 191
Consolidated Net Income / (Loss)		 150 113 55 191
Depreciation Expense		 22 26 41 56
Amortization Expense		 1.21 6.07 3.12 3.15
Non-Cash Adjustments To Reconcile Net Income		 15 21 133 97
Changes in Operating Assets and Liabilities, net		 -96 -102 135 57
Net Cash From Investing Activities		 -75 -173 -443 -264
Net Cash From Continuing Investing Activities		 -75 -173 -443 -264
Purchase of Property, Plant & Equipment		 -78 -173 -350 -249
Acquisitions		 0.00 -2.60 -33 0.00
Purchase of Investments		 0.00 0.00 -91 -21
Sale of Property, Plant & Equipment		 0.01 0.75 1.50 0.75
Sale and/or Maturity of Investments		 0.00 0.00 26 0.00
Other Investing Activities, net		 - 1.86 3.52 5.59
Net Cash From Financing Activities		 12 130 117 -69
Net Cash From Continuing Financing Activities		 12 130 117 -69
Repayment of Debt		 -173 -1,058 -1,073 -60
Payment of Dividends		 -60 -80 -34 -0.38
Issuance of Debt		 242 1,267 748 0.00
Issuance of Common Equity		 3.25 0.59 510 0.00
Other Financing Activities, net		 0.00 0.00 -34 -8.40
Cash Interest Paid		 26 51 48 41
Cash Income Taxes Paid		 43 60 108 84

Quarterly Cash Flow Statements for PACS Group

This table details how cash moves in and out of PACS Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q4 2025 Q1 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 37 -54 9.63 29 -25 -15 -16 99 130 -127 42
Net Cash From Operating Activities		 79 -21 15 -9.70 59 35 209 65 150 -3.39 236
Net Cash From Continuing Operating Activities		 79 -21 15 -9.70 59 35 209 65 150 -3.39 236
Net Income / (Loss) Continuing Operations		 38 21 20 34 35 -11 -19 36 28 60 81
Consolidated Net Income / (Loss)		 38 21 20 34 35 -11 -19 36 28 60 81
Depreciation Expense		 5.83 6.16 6.36 7.28 8.12 8.78 11 13 13 15 18
Amortization Expense		 0.62 3.66 0.55 1.24 0.78 0.78 0.78 0.78 0.79 0.79 0.79
Non-Cash Adjustments To Reconcile Net Income		 3.98 4.31 6.08 6.74 6.86 102 27 26 24 26 31
Changes in Operating Assets and Liabilities, net		 31 -56 -18 -59 8.18 -65 189 -11 85 -106 106
Net Cash From Investing Activities		 -58 -9.71 -46 -60 -119 -121 -99 -104 -16 -118 -127
Net Cash From Continuing Investing Activities		 -58 -9.71 -46 -60 -119 -121 -99 -104 -16 -118 -127
Purchase of Property, Plant & Equipment		 -58 -11 -46 -58 -89 -111 -66 -83 -18 -114 -108
Purchase of Investments		 0.00 - - - -25 -10 -10 -46 0.00 -6.05 -20
Divestitures		 - - - - 0.67 - - 1.31 1.30 - 1.44
Net Cash From Financing Activities		 15 -24 40 98 34 71 -126 139 -4.07 -5.47 -68
Net Cash From Continuing Financing Activities		 15 -24 40 98 34 71 -126 139 -4.07 -5.47 -68
Repayment of Debt		 -44 -415 -100 -498 -105 -465 -366 -138 -4.07 -5.47 -101
Payment of Dividends		 -19 -25 -25 -11 -17 -16 - - 0.00 0.00 -0.21
Issuance of Debt		 78 416 165 608 157 171 144 276 0.00 - 45
Other Financing Activities, net		 - - - - - - - 0.00 0.00 - -11
Cash Interest Paid		 9.93 18 7.39 15 16 9.91 14 8.90 8.09 12 9.10
Cash Income Taxes Paid		 0.00 17 35 8.17 0.00 43 34 30 0.36 3.00 0.33

Annual Balance Sheets for PACS Group

This table presents PACS Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 3,513 5,243 5,584
Total Current Assets		 722 938 1,070
Cash & Equivalents		 73 158 197
Accounts Receivable		 600 717 702
Prepaid Expenses		 49 64 171
Plant, Property, & Equipment, net		 578 991 1,201
Total Noncurrent Assets		 2,213 3,314 3,313
Goodwill		 65 67 68
Other Noncurrent Operating Assets		 2,148 3,247 3,245
Total Liabilities & Shareholders' Equity		 3,513 5,243 5,584
Total Liabilities		 3,411 4,527 4,632
Total Current Liabilities		 457 978 1,001
Short-Term Debt		 17 157 4.46
Accounts Payable		 141 175 192
Accrued Expenses		 70 142 154
Current Employee Benefit Liabilities		 92 146 188
Other Current Liabilities		 137 358 463
Total Noncurrent Liabilities		 2,954 3,549 3,630
Long-Term Debt		 716 251 345
Asset Retirement Reserve & Litigation Obligation		 146 165 193
Other Noncurrent Operating Liabilities		 2,092 3,133 3,093
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 102 716 952
Total Preferred & Common Equity		 96 710 947
Total Common Equity		 96 710 947
Common Stock		 0.13 592 637
Retained Earnings		 96 118 310
Noncontrolling Interest		 5.60 6.14 5.68

Quarterly Balance Sheets for PACS Group

This table presents PACS Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 3,861 3,933 4,517 5,494 5,502 5,627 5,664
Total Current Assets		 821 764 735 1,081 1,077 1,127 1,068
Cash & Equivalents		 81 73 50 288 294 356 248
Accounts Receivable		 678 631 624 742 690 695 733
Prepaid Expenses		 62 60 61 52 93 76 87
Plant, Property, & Equipment, net		 667 857 925 999 1,032 0.00 1,308
Total Noncurrent Assets		 2,373 2,312 2,857 3,414 3,392 4,500 3,287
Goodwill		 65 65 65 67 67 68 68
Other Noncurrent Operating Assets		 2,308 2,247 2,792 3,347 3,325 4,432 3,219
Total Liabilities & Shareholders' Equity		 3,861 3,933 4,517 5,494 5,502 5,627 5,664
Total Liabilities		 3,741 3,390 3,850 4,738 4,690 4,750 4,621
Total Current Liabilities		 535 488 682 1,107 1,167 1,198 1,074
Short-Term Debt		 17 16 16 155 152 107 8.39
Accounts Payable		 157 126 155 199 172 205 181
Accrued Expenses		 71 75 107 164 248 179 168
Current Employee Benefit Liabilities		 144 99 155 210 193 253 243
Other Current Liabilities		 147 172 249 379 402 453 473
Total Noncurrent Liabilities		 2,662 2,647 3,168 3,631 3,522 3,552 3,548
Long-Term Debt		 231 227 254 249 247 246 285
Asset Retirement Reserve & Litigation Obligation		 155 172 188 187 208 177 209
Other Noncurrent Operating Liabilities		 2,276 2,248 2,726 3,195 3,068 3,129 3,054
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 119 543 667 756 813 877 1,042
Total Preferred & Common Equity		 114 537 660 750 807 871 1,037
Total Common Equity		 113 537 660 750 807 871 1,037
Common Stock		 0.13 472 579 604 609 621 647
Retained Earnings		 113 65 81 147 197 250 390
Noncontrolling Interest		 5.60 6.11 6.70 6.05 5.83 5.59 5.02

Annual Metrics And Ratios for PACS Group

This table displays calculated financial ratios and metrics derived from PACS Group's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - -
Revenue Growth		 0.00% 28.47% 31.44% 29.32%
EBITDA Growth		 0.00% -6.70% -20.56% 95.78%
EBIT Growth		 0.00% -10.90% -29.60% 114.41%
NOPAT Growth		 0.00% -10.58% -55.01% 210.69%
Net Income Growth		 0.00% -24.99% -50.97% 245.95%
EPS Growth		 0.00% -24.79% -56.82% 221.05%
Operating Cash Flow Growth		 0.00% -31.22% 476.70% 10.04%
Free Cash Flow Firm Growth		 0.00% 0.00% 77.45% 150.41%
Invested Capital Growth		 0.00% 0.00% 26.95% 14.38%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - -
Gross Margin		 23.15% 21.33% 19.38% 21.92%
EBITDA Margin		 10.57% 7.68% 4.64% 7.03%
Operating Margin		 9.47% 6.68% 3.01% 5.85%
EBIT Margin		 9.60% 6.66% 3.57% 5.91%
Profit (Net Income) Margin		 6.21% 3.63% 1.35% 3.62%
Tax Burden Percent		 72.69% 71.75% 54.50% 67.31%
Interest Burden Percent		 89.02% 75.91% 69.61% 90.93%
Effective Tax Rate		 27.31% 28.25% 45.50% 32.69%
Return on Invested Capital (ROIC)		 0.00% 39.19% 7.77% 20.13%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 28.20% 5.19% 11.72%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 182.74% 5.77% 2.83%
Return on Equity (ROE)		 0.00% 221.93% 13.54% 22.96%
Cash Return on Invested Capital (CROIC)		 0.00% -160.81% -15.98% 6.72%
Operating Return on Assets (OROA)		 0.00% 5.90% 3.33% 5.78%
Return on Assets (ROA)		 0.00% 3.21% 1.26% 3.54%
Return on Common Equity (ROCE)		 0.00% 209.72% 13.35% 22.79%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 167 149 67 208
NOPAT Margin		 6.88% 4.79% 1.64% 3.94%
Net Nonoperating Expense Percent (NNEP)		 0.00% 10.99% 2.58% 8.41%
Return On Investment Capital (ROIC_SIMPLE)		 - 17.87% 5.97% 16.01%
Cost of Revenue to Revenue		 76.85% 78.67% 80.62% 78.08%
SG&A Expenses to Revenue		 6.15% 6.87% 8.41% 7.85%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 13.68% 14.66% 16.37% 16.06%
Earnings before Interest and Taxes (EBIT)		 233 207 146 313
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 256 239 190 372
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 4.68 2.82 6.35
Price to Tangible Book Value (P/TBV)		 0.00 14.59 3.11 6.84
Price to Revenue (P/Rev)		 0.19 0.14 0.49 1.14
Price to Earnings (P/E)		 2.99 3.99 35.83 31.39
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 33.44% 25.08% 2.79% 3.19%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.47 2.33 5.59
Enterprise Value to Revenue (EV/Rev)		 0.00 0.36 0.55 1.17
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 4.67 11.88 16.60
Enterprise Value to EBIT (EV/EBIT)		 0.00 5.38 15.45 19.73
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 7.48 33.61 29.61
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 17.50 6.14 15.26
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 88.73
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 7.20 0.57 0.37
Long-Term Debt to Equity		 0.00 7.04 0.35 0.36
Financial Leverage		 0.00 6.48 1.11 0.24
Leverage Ratio		 0.00 34.53 10.71 6.49
Compound Leverage Factor		 0.00 26.21 7.46 5.90
Debt to Total Capital		 0.00% 87.81% 36.30% 26.83%
Short-Term Debt to Total Capital		 0.00% 2.02% 13.96% 0.34%
Long-Term Debt to Total Capital		 0.00% 85.79% 22.34% 26.49%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.67% 0.55% 0.44%
Common Equity to Total Capital		 0.00% 11.52% 63.15% 72.73%
Debt to EBITDA		 0.00 3.07 2.15 0.94
Net Debt to EBITDA		 0.00 2.76 1.32 0.41
Long-Term Debt to EBITDA		 0.00 3.00 1.32 0.93
Debt to NOPAT		 0.00 4.91 6.08 1.68
Net Debt to NOPAT		 0.00 4.42 3.73 0.73
Long-Term Debt to NOPAT		 0.00 4.80 3.74 1.65
Altman Z-Score		 0.00 1.29 1.16 2.00
Noncontrolling Interest Sharing Ratio		 0.00% 5.51% 1.44% 0.71%
Liquidity Ratios		 - - - -
Current Ratio		 0.00 1.58 0.96 1.07
Quick Ratio		 0.00 1.47 0.89 0.90
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -612 -138 70
Operating Cash Flow to CapEx		 118.39% 37.02% 105.46% 162.73%
Free Cash Flow to Firm to Interest Expense		 0.00 -12.25 -3.11 2.45
Operating Cash Flow to Interest Expense		 3.63 1.28 8.28 14.25
Operating Cash Flow Less CapEx to Interest Expense		 0.56 -2.17 0.43 5.49
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.89 0.93 0.98
Accounts Receivable Turnover		 0.00 5.19 6.21 7.46
Inventory Turnover		 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 5.39 0.00 4.83
Accounts Payable Turnover		 0.00 17.37 20.87 22.49
Days Sales Outstanding (DSO)		 0.00 70.39 58.75 48.95
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 21.02 17.49 16.23
Cash Conversion Cycle (CCC)		 0.00 49.37 41.26 32.72
Capital & Investment Metrics		 - - - -
Invested Capital		 0.00 761 966 1,105
Invested Capital Turnover		 0.00 8.18 4.74 5.11
Increase / (Decrease) in Invested Capital		 0.00 761 205 139
Enterprise Value (EV)		 0.00 1,115 2,254 6,170
Market Capitalization		 450 450 1,998 6,012
Book Value per Share		 $0.00 $0.75 $4.66 $6.05
Tangible Book Value per Share		 $0.00 $0.24 $4.22 $5.61
Total Capital		 0.00 834 1,124 1,302
Total Debt		 0.00 733 408 349
Total Long-Term Debt		 0.00 716 251 345
Net Debt		 0.00 659 250 152
Capital Expenditures (CapEx)		 78 172 348 248
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 209 -41 -124
Debt-free Net Working Capital (DFNWC)		 0.00 282 117 73
Net Working Capital (NWC)		 0.00 265 -40 68
Net Nonoperating Expense (NNE)		 16 36 12 17
Net Nonoperating Obligations (NNO)		 0.00 659 250 152
Total Depreciation and Amortization (D&A)		 24 32 44 59
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 6.71% -1.00% -2.35%
Debt-free Net Working Capital to Revenue		 0.00% 9.06% 2.85% 1.38%
Net Working Capital to Revenue		 0.00% 8.52% -0.98% 1.29%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.38 $1.23
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 146.66M 156.18M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.38 $1.22
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 148.57M 156.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 157.17M
Normalized Net Operating Profit after Tax (NOPAT)		 167 149 67 208
Normalized NOPAT Margin		 6.88% 4.79% 1.64% 3.94%
Pre Tax Income Margin		 8.55% 5.06% 2.48% 5.38%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 9.11 4.15 3.29 11.03
NOPAT to Interest Expense		 6.53 2.99 1.51 7.35
EBIT Less CapEx to Interest Expense		 6.04 0.70 -4.56 2.27
NOPAT Less CapEx to Interest Expense		 3.47 -0.46 -6.34 -1.41
Payout Ratios		 - - - -
Dividend Payout Ratio		 40.05% 71.22% 60.93% 0.20%
Augmented Payout Ratio		 40.05% 71.22% 60.93% 0.20%

Quarterly Metrics And Ratios for PACS Group

This table displays calculated financial ratios and metrics derived from PACS Group's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 157,165,029.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 157,165,029.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.51
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 31.94% 29.08% 0.00% 0.00% 38.85% 39.92% 31.01% 12.43% 11.22%
EBITDA Growth		 0.00% 0.00% 46.76% -88.79% 0.00% 0.00% -23.66% 411.75% 81.46% 32.49% 120.23%
EBIT Growth		 0.00% 0.00% 48.06% -106.81% 0.00% 0.00% -32.74% 301.94% 98.72% 35.30% 142.09%
NOPAT Growth		 0.00% 0.00% 18.45% -98.51% 0.00% 0.00% -18.87% 300.53% 434.98% 53.19% 166.27%
Net Income Growth		 0.00% 0.00% 30.70% -151.40% 0.00% 0.00% -18.49% 259.89% 222.83% 65.19% 184.24%
EPS Growth		 0.00% 0.00% 31.03% -143.75% 0.00% 0.00% -37.04% 247.62% 220.00% 90.91% 194.12%
Operating Cash Flow Growth		 0.00% 0.00% -25.86% 265.16% 0.00% 0.00% 155.73% 0.00% 0.00% -105.25% 57.30%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 98.56% 110.24% 0.00% 54.67% -1,040.96%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.22% -5.12% 0.00% 14.38% 24.59%
Revenue Q/Q Growth		 3.75% 8.11% 0.00% 5.04% 4.53% 17.69% 0.00% 0.00% 0.00% 1.00% 4.60%
EBITDA Q/Q Growth		 -21.50% 60.61% 0.00% -93.45% 760.19% 53.98% 0.00% 0.00% 0.00% 12.42% 24.62%
EBIT Q/Q Growth		 -19.80% 67.48% 0.00% -103.61% 1,435.99% 65.16% 0.00% 0.00% 0.00% 12.45% 25.97%
NOPAT Q/Q Growth		 -20.43% 63.76% 0.00% -99.08% 2,125.42% 284.86% 0.00% 0.00% 0.00% 10.20% 30.56%
Net Income Q/Q Growth		 -6.09% 71.31% 0.00% -122.20% 248.61% 123.26% 0.00% 0.00% 0.00% 14.25% 34.93%
EPS Q/Q Growth		 -6.25% 86.67% 0.00% -118.42% 242.86% 120.00% 0.00% 0.00% 0.00% 31.25% 19.05%
Operating Cash Flow Q/Q Growth		 172.05% -163.88% 0.00% -40.78% 500.78% -69.12% 0.00% 0.00% 0.00% 0.00% 7,071.53%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -27.06% 100.00% 0.00% 0.00% 0.00% 0.00% 90.97% -75.81%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 18.95% -100.00% 0.00% 0.00% 0.00% 0.00% 26.31% -1.57%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 19.10% 20.34% 21.26% 22.38% 17.22% 21.40% 19.84% 22.02% 22.19% 23.51% 24.35%
EBITDA Margin		 5.64% 8.38% 10.39% 0.65% 5.33% 6.97% 4.94% 7.34% 7.38% 8.21% 9.79%
Operating Margin		 4.61% 7.33% 8.55% 0.07% 2.24% 5.96% 3.77% 6.15% 6.42% 6.97% 8.45%
EBIT Margin		 4.77% 7.38% 9.46% -0.33% 4.16% 5.84% 3.89% 6.34% 6.31% 7.02% 8.46%
Profit (Net Income) Margin		 2.53% 4.00% 5.26% -1.11% 1.58% 3.00% 2.22% 3.89% 3.89% 4.40% 5.68%
Tax Burden Percent		 72.74% 69.34% 67.26% 88.10% 48.16% 59.14% 66.42% 64.83% 68.59% 68.87% 70.93%
Interest Burden Percent		 72.84% 78.16% 82.60% 387.54% 78.85% 86.81% 86.09% 94.75% 89.95% 91.01% 94.65%
Effective Tax Rate		 27.26% 30.66% 32.74% 0.00% 51.84% 40.86% 33.58% 35.17% 31.41% 31.13% 29.07%
Return on Invested Capital (ROIC)		 0.00% 20.78% 0.00% 0.00% 0.00% 14.92% 0.00% 0.00% 0.00% 24.53% 33.22%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 19.38% 0.00% 0.00% 0.00% 12.37% 0.00% 0.00% 0.00% 21.84% 27.69%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 125.60% 0.00% 0.00% 0.00% 4.33% 0.00% 0.00% 0.00% 5.27% 2.49%
Return on Equity (ROE)		 0.00% 146.38% 0.00% 0.00% 0.00% 19.25% 0.00% 0.00% 0.00% 29.80% 35.71%
Cash Return on Invested Capital (CROIC)		 0.00% -80.41% 0.00% 0.00% 0.00% -14.28% -5.09% 0.00% 0.00% 6.72% 4.80%
Operating Return on Assets (OROA)		 0.00% 6.54% 0.00% 0.00% 0.00% 5.45% 0.00% 0.00% 0.00% 6.86% 8.24%
Return on Assets (ROA)		 0.00% 3.54% 0.00% 0.00% 0.00% 2.80% 0.00% 0.00% 0.00% 4.30% 5.53%
Return on Common Equity (ROCE)		 0.00% 138.32% 0.00% 0.00% 0.00% 18.97% 0.00% 0.00% 0.00% 29.59% 35.49%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 26 43 54 0.50 11 43 32 52 59 65 85
NOPAT Margin		 3.36% 5.08% 5.75% 0.05% 1.08% 3.52% 2.50% 3.99% 4.40% 4.80% 5.99%
Net Nonoperating Expense Percent (NNEP)		 0.00% 1.40% 1.32% 5.46% 0.00% 2.55% 0.87% 0.46% -596.10% 2.70% 5.52%
Return On Investment Capital (ROIC_SIMPLE)		 - 5.20% - - - 3.79% 2.76% 4.31% 4.81% 5.01% 6.38%
Cost of Revenue to Revenue		 80.91% 79.66% 78.74% 77.62% 82.78% 78.60% 80.16% 77.98% 77.81% 76.49% 75.65%
SG&A Expenses to Revenue		 6.28% 4.92% 5.02% 14.71% 6.88% 7.42% 7.73% 7.66% 7.63% 8.36% 7.91%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 14.48% 13.01% 12.71% 22.30% 14.98% 15.44% 16.07% 15.88% 15.77% 16.53% 15.90%
Earnings before Interest and Taxes (EBIT)		 38 63 88 -3.20 43 70 50 83 85 95 120
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 45 72 97 6.36 55 84 63 96 99 112 139
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 4.68 3.52 1.27 0.00 2.82 2.28 2.44 2.40 6.35 4.87
Price to Tangible Book Value (P/TBV)		 0.00 14.59 7.18 1.43 0.00 3.11 2.51 2.66 2.60 6.84 5.21
Price to Revenue (P/Rev)		 0.00 0.14 0.00 0.00 0.00 0.49 0.00 0.00 0.00 1.14 0.93
Price to Earnings (P/E)		 0.00 3.99 0.00 0.00 0.00 35.83 0.00 0.00 0.00 31.39 20.71
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 25.08% 0.00% 0.00% 0.00% 2.79% 0.00% 0.00% 0.00% 3.19% 4.83%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.47 1.38 1.16 0.00 2.33 2.10 2.27 2.40 5.59 4.69
Enterprise Value to Revenue (EV/Rev)		 0.00 0.36 0.00 0.00 0.00 0.55 0.00 0.00 0.00 1.17 0.94
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 4.67 0.00 0.00 0.00 11.88 0.00 0.00 0.00 16.60 11.39
Enterprise Value to EBIT (EV/EBIT)		 0.00 5.38 0.00 0.00 0.00 15.45 0.00 0.00 0.00 19.73 13.30
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 7.48 0.00 0.00 0.00 33.61 0.00 0.00 0.00 29.61 19.49
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 17.50 0.00 0.00 0.00 6.14 0.00 0.00 0.00 15.26 10.40
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 88.73 108.47
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 7.20 5.87 0.85 0.00 0.57 0.53 0.49 0.40 0.37 0.28
Long-Term Debt to Equity		 0.00 7.04 5.75 0.82 0.00 0.35 0.33 0.30 0.28 0.36 0.27
Financial Leverage		 0.00 6.48 5.27 0.72 0.00 0.35 0.94 0.39 0.00 0.24 0.09
Leverage Ratio		 0.00 34.53 28.94 6.74 0.00 10.71 10.68 6.96 6.42 6.49 6.20
Compound Leverage Factor		 0.00 26.99 23.90 26.11 0.00 9.30 9.20 6.59 5.77 5.91 5.87
Debt to Total Capital		 0.00% 87.81% 85.45% 45.91% 0.00% 36.30% 34.82% 32.94% 28.72% 26.83% 21.96%
Short-Term Debt to Total Capital		 0.00% 2.02% 1.83% 1.47% 0.00% 13.96% 13.35% 12.56% 8.74% 0.34% 0.63%
Long-Term Debt to Total Capital		 0.00% 85.79% 83.62% 44.44% 0.00% 22.34% 21.47% 20.38% 19.99% 26.49% 21.33%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.67% 0.61% 0.57% 0.00% 0.55% 0.52% 0.48% 0.45% 0.44% 0.38%
Common Equity to Total Capital		 0.00% 11.52% 13.94% 53.52% 0.00% 63.15% 64.66% 66.58% 70.82% 72.73% 77.67%
Debt to EBITDA		 0.00 3.07 0.00 0.00 0.00 2.15 0.00 0.00 0.00 0.94 0.66
Net Debt to EBITDA		 0.00 2.76 0.00 0.00 0.00 1.32 0.00 0.00 0.00 0.41 0.10
Long-Term Debt to EBITDA		 0.00 3.00 0.00 0.00 0.00 1.32 0.00 0.00 0.00 0.93 0.64
Debt to NOPAT		 0.00 4.91 0.00 0.00 0.00 6.08 0.00 0.00 0.00 1.68 1.12
Net Debt to NOPAT		 0.00 4.42 0.00 0.00 0.00 3.73 0.00 0.00 0.00 0.73 0.17
Long-Term Debt to NOPAT		 0.00 4.80 0.00 0.00 0.00 3.74 0.00 0.00 0.00 1.65 1.09
Altman Z-Score		 0.00 1.15 0.29 0.27 0.00 1.11 0.28 0.00 0.00 1.87 1.78
Noncontrolling Interest Sharing Ratio		 0.00% 5.51% 4.19% 1.06% 0.00% 1.44% 1.35% 0.00% 0.00% 0.71% 0.62%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.58 1.56 1.71 0.00 0.96 0.98 0.92 0.94 1.07 1.00
Quick Ratio		 0.00 1.47 1.45 1.57 0.00 0.89 0.93 0.84 0.88 0.90 0.91
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -783 -995 0.00 0.00 -11 102 -815 -74 -129
Operating Cash Flow to CapEx		 32.99% -16.78% 65.86% 31.23% 324.81% 77.66% 848.02% 0.00% 0.00% -2.99% 218.13%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -50.89 -108.33 0.00 0.00 -1.64 23.36 -95.61 -8.59 -20.15
Operating Cash Flow to Interest Expense		 1.49 -0.71 3.82 3.79 23.16 6.94 21.76 0.00 0.00 -0.40 36.79
Operating Cash Flow Less CapEx to Interest Expense		 -3.02 -4.91 -1.98 -8.35 16.03 -2.00 19.20 0.00 0.00 -13.63 19.92
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.89 0.00 0.00 0.00 0.93 0.00 0.00 0.00 0.98 0.97
Accounts Receivable Turnover		 0.00 5.19 0.00 0.00 0.00 6.21 0.00 0.00 0.00 7.46 7.37
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 5.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.83 4.71
Accounts Payable Turnover		 0.00 17.37 0.00 0.00 0.00 20.87 0.00 0.00 0.00 22.49 22.04
Days Sales Outstanding (DSO)		 0.00 70.39 0.00 0.00 0.00 58.75 0.00 0.00 0.00 48.95 49.55
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 21.02 0.00 0.00 0.00 17.49 0.00 0.00 0.00 16.23 16.56
Cash Conversion Cycle (CCC)		 0.00 49.37 0.00 0.00 0.00 41.26 0.00 0.00 0.00 32.72 32.99
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 761 837 996 0.00 966 873 918 875 1,105 1,087
Invested Capital Turnover		 0.00 4.09 0.00 0.00 0.00 4.23 0.00 0.00 0.00 5.11 5.54
Increase / (Decrease) in Invested Capital		 0.00 0.00 837 996 0.00 0.00 43 -50 875 139 215
Enterprise Value (EV)		 0.00 1,115 1,159 1,151 0.00 2,254 1,836 2,080 2,096 6,170 5,098
Market Capitalization		 450 450 450 727 6,091 1,998 1,713 1,969 2,092 6,012 5,048
Book Value per Share		 $0.00 $0.75 $0.99 $3.83 $0.00 $4.66 $4.92 $5.29 $5.72 $6.05 $6.60
Tangible Book Value per Share		 $0.00 $0.24 $0.49 $3.39 $0.00 $4.22 $4.48 $4.85 $5.27 $5.61 $6.17
Total Capital		 0.00 834 918 1,069 0.00 1,124 1,160 1,212 1,230 1,302 1,335
Total Debt		 0.00 733 785 491 0.00 408 404 399 353 349 293
Total Long-Term Debt		 0.00 716 768 475 0.00 251 249 247 246 345 285
Net Debt		 0.00 659 703 417 0.00 250 117 105 -2.30 152 45
Capital Expenditures (CapEx)		 46 58 89 111 64 83 18 0.00 0.00 114 108
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 209 236 275 0.00 -41 -159 -232 -319 -124 -245
Debt-free Net Working Capital (DFNWC)		 0.00 282 317 348 0.00 117 129 62 37 73 2.97
Net Working Capital (NWC)		 0.00 265 300 333 0.00 -40 -26 -90 -71 68 -5.42
Net Nonoperating Expense (NNE)		 6.55 9.22 4.64 11 -5.15 6.38 3.59 1.22 6.84 5.42 4.47
Net Nonoperating Obligations (NNO)		 0.00 659 703 417 0.00 250 117 105 -2.30 152 45
Total Depreciation and Amortization (D&A)		 6.91 8.52 8.68 9.55 12 14 13 13 14 16 19
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 6.71% 0.00% 0.00% 0.00% -1.00% 0.00% 0.00% 0.00% -2.35% -4.51%
Debt-free Net Working Capital to Revenue		 0.00% 9.06% 0.00% 0.00% 0.00% 2.85% 0.00% 0.00% 0.00% 1.38% 0.05%
Net Working Capital to Revenue		 0.00% 8.52% 0.00% 0.00% 0.00% -0.98% 0.00% 0.00% 0.00% 1.29% -0.10%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.28 $0.38 ($0.07) $0.00 $0.22 $0.18 $0.33 $0.33 $0.39 $0.51
Adjusted Weighted Average Basic Shares Outstanding		 0.00 128.72M 128.72M 149.46M 0.00 146.66M 155.18M 156.34M 156.58M 156.18M 157.07M
Adjusted Diluted Earnings per Share		 $0.00 $0.28 $0.38 ($0.07) $0.00 $0.22 $0.17 $0.31 $0.32 $0.42 $0.50
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 128.72M 128.72M 149.46M 0.00 148.57M 166.42M 165.47M 164.71M 156.70M 162.08M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 24.64M 152.40M 0.00 0.00 0.00 0.00 156.62M 157.17M 158.27M
Normalized Net Operating Profit after Tax (NOPAT)		 26 43 54 0.50 16 43 32 52 59 65 85
Normalized NOPAT Margin		 3.36% 5.08% 5.75% 0.05% 1.57% 3.52% 2.50% 3.99% 4.40% 4.80% 5.99%
Pre Tax Income Margin		 3.47% 5.77% 7.82% -1.26% 3.28% 5.07% 3.35% 6.00% 5.67% 6.39% 8.01%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.68 4.58 5.75 -0.35 4.73 7.58 7.19 19.06 9.95 11.12 18.70
NOPAT to Interest Expense		 2.59 3.15 3.49 0.05 1.23 4.58 4.63 11.99 6.94 7.60 13.25
EBIT Less CapEx to Interest Expense		 -0.82 0.38 -0.05 -12.48 -2.40 -1.36 4.62 0.00 0.00 -2.11 1.84
NOPAT Less CapEx to Interest Expense		 -1.91 -1.05 -2.31 -12.08 -5.91 -4.37 2.06 0.00 0.00 -5.63 -3.61
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 71.22% 0.00% 0.00% 0.00% 60.93% 0.00% 0.00% 0.00% 0.20% 0.24%
Augmented Payout Ratio		 0.00% 71.22% 0.00% 0.00% 0.00% 60.93% 0.00% 0.00% 0.00% 0.20% 0.24%

Financials Breakdown Chart

Key Financial Trends

PACS Group’s latest quarter shows continued top-line growth and a sharp rebound in profitability, but the balance sheet remains highly leveraged and working-capital heavy. Revenue in Q1 2026 rose to $1.42 billion from $1.36 billion in Q4 2025 and $1.28 billion in Q1 2025, while net income improved to $80.7 million. Cash from operations was also strong at $236.3 million, helped by a sizable working-capital inflow.

Over the last several years, the big trend is growth accompanied by leverage: PACS has scaled revenue from $708.4 million in Q1 2023 to $1.42 billion in Q1 2026, but liabilities have also grown materially. The company continues to rely on debt and large noncurrent operating liabilities, which makes profitability and cash conversion especially important.

  • Revenue is still growing. Q1 2026 revenue increased about 11.9% year over year from Q1 2025, showing the business is still expanding.
  • Gross profit and operating income improved year over year. Gross profit rose to $346.0 million from $253.4 million in Q1 2025, and operating income climbed to $120.0 million from $48.1 million.
  • Net income nearly tripled from Q1 2025. Net income attributable to common shareholders increased to $80.7 million from $28.5 million.
  • Operating cash flow was strong. PACS generated $236.3 million from operations in Q1 2026, well above the prior-year quarter’s $150.2 million.
  • Cash on hand improved sequentially. Cash & equivalents rose to $248.0 million at March 31, 2026 from $355.7 million in Q3 2025, but the latest quarter still ended with healthy liquidity after strong cash generation.
  • EBITDA-style cash earnings remain supported by non-cash items. Depreciation, amortization, and other non-cash adjustments continue to be meaningful contributors to cash flow.
  • Shares outstanding remain elevated. Diluted shares were about 162.1 million in Q1 2026, which can dampen per-share growth even when net income rises.
  • Working capital is a recurring challenge. Accounts receivable alone stood at $733.2 million in Q1 2026, a large balance that ties up cash and can pressure liquidity if collections slow.
  • Debt and liabilities are still large. Total liabilities were $4.62 billion versus total equity of just $1.04 billion, indicating a highly leveraged capital structure.
  • Operating cash flow can be volatile quarter to quarter. PACS produced negative operating cash flow in Q4 2025 before rebounding sharply in Q1 2026, suggesting the business may be sensitive to timing of receivables, payables, and other working-capital items.

Bottom line: PACS is growing quickly and recently delivered better profitability and cash generation, which is encouraging. The main risk is the balance sheet: leverage, large receivables, and heavy liabilities mean investors should watch collections, margins, and operating cash flow closely.

06/21/26 05:36 AM ETAI Generated. May Contain Errors.

PACS Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, PACS Group's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

PACS Group's net income appears to be on an upward trend, with a most recent value of $191.46 million in 2025, rising from $150.50 million in 2022. The previous period was $55.34 million in 2024. See where experts think PACS Group is headed by visiting PACS Group's forecast page.

PACS Group's total operating income in 2025 was $309.60 million, based on the following breakdown:
  • Total Gross Profit: $1.16 billion
  • Total Operating Expenses: $849.64 million

Over the last 3 years, PACS Group's total revenue changed from $2.42 billion in 2022 to $5.29 billion in 2025, a change of 118.4%.

PACS Group's total liabilities were at $4.63 billion at the end of 2025, a 2.3% increase from 2024, and a 35.8% increase since 2023.

In the past 2 years, PACS Group's cash and equivalents has ranged from $73.42 million in 2023 to $197.02 million in 2025, and is currently $197.02 million as of their latest financial filing in 2025.

Over the last 3 years, PACS Group's book value per share changed from 0.00 in 2022 to 6.05 in 2025, a change of 604.5%.


Related Companies

Financial statements for NYSE:PACS last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....
InvestPub | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel